Hair aging and anti-aging

References

• Tobin DJ, Paus R. Graying: gerontobiology of the hair follicle pigmentary unit. Exp. Gerontol.36, 29–54 (2001).
   PubMed Web of Science ®Google Scholar
• Gummer CH, Schiel S. Amino acids – a potential solution for cosmetic hair problems. Poster. Presented at: The 4th Intercontinental Meeting of Hair Research Societies. Berlin, Germany, 17–19 June 2004.
   Google Scholar
• Dawber R. Hair: Its structure and response to cosmetic preparations. Clin. Dermatol.14, 105–112 (1996).
   PubMed Web of Science ®Google Scholar
• Feldmann KA, Dawber RPR, Pittelkow MR, Ferguson DJP. Newly described weathering pattern in pili annulati hair shafts: a scanning electron microscopic study. J. Am. Acad. Dermatol.45, 625–627 (2001).
   PubMed Web of Science ®Google Scholar
• Hofbauer GFL, Tsambaos D, Spycher MA, Trüeb RM. Acquired hair fragility in pili anulati: causal relationship with androgenetic alopecia. Dermatology203, 60–62 (2001).
   PubMed Web of Science ®Google Scholar
• Commo S, Gaillard O, Bernard BA. Human hair greying is linked to a specific depletion of hair follicle melanocytes affecting both the bulb and the outer root sheath. Br. J. Dermatol.150, 435–443 (2004).
   PubMed Web of Science ®Google Scholar
• Nishimura EK, Jordan SA, Ohima H et al. Dominant role of the niche in melanocyte stem-cell fate determination. Nature416, 854–860 (2002).
   PubMed Web of Science ®Google Scholar
• Nishimura EK, Granter SR, Fisher DE. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science307, 720–724 (2005).
   PubMed Web of Science ®Google Scholar
• Nagl W. Different growth rates of pigmented and white hair in the beard: differentiation vs. proliferation? Br. J. Dermatol.132, 94–97 (1995).
   PubMed Web of Science ®Google Scholar
• van Neste D. Thickness, medullation and growth rate of female scalp hair are subject to significant variation according to pigmentation of scalp location during aging. Eur. J. Dermatol.14, 28–32 (2004).
   PubMed Web of Science ®Google Scholar
• van Neste D, Tobin DJ. Hair cycle and hair pigmentation: dynamic interactions and changes associated with aging. Micron35, 193–200 (2004).
   PubMed Web of Science ®Google Scholar
• Norwood OT. Male pattern baldness: classification and incidence. South. Med. J.68, 1359–1365 (1975).
   PubMed Web of Science ®Google Scholar
• Norwood OT. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol. Surg.27, 53–54 (2001).
   PubMed Web of Science ®Google Scholar
• Trüeb RM. Molecular mechanisms in androgenetic alopecia. Exp. Gerontol.37, 981–990 (2002).
   PubMed Web of Science ®Google Scholar
• Whiting DA. Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. J. Am. Acad. Dermatol.45(Suppl.) S81–S86 (2001).
   PubMed Web of Science ®Google Scholar
• Kaufman KD. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermatol. Clin.14, 697–711 (1996).
   PubMed Web of Science ®Google Scholar
• Randall VA, Thornton MH, Messenger AG. Cultured dermal papilla cells from androgen-dependent human hair follicles (e.g. beard) contain more androgen receptors than those from non-balding areas of the scalp. J. Endocrinol.133, 141–147 (1992).
   PubMed Web of Science ®Google Scholar
• Itami S, Kurata S, Takayasu S. Androgen induction of follicular epithelial cell growth mediated via insulin-like growth factor I from dermal papilla cells. Biochem. Biophys. Res. Commun.221, 988–994 (1995).
   Google Scholar
• Hibberts NA, Messenger AG, Randall VA. Dermal papilla cells derived from beard hair follicles secrete more stem cell factor (SCF) in culture than scalp cells or dermal fibroblasts. Biochem. Biophys. Res. Commun.222, 401–405 (1996).
   PubMed Web of Science ®Google Scholar
• Orme S, Cullen DR, Messenger AG. Diffuse female hair loss: are androgens necessary? Br. J. Dermatol.141, 521–523 (1999).
   PubMed Web of Science ®Google Scholar
• Vexiau P, Chaspoux C, Boudou P et al. Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br. J. Dermatol.146, 992–999 (2002).
   PubMed Web of Science ®Google Scholar
• Price VH, Roberts JL, Hordinsky M et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J. Am. Acad. Dermatol.43, 768–776 (2000).
   PubMed Web of Science ®Google Scholar
• Venning VA, Dawber RPR. Patterned androgenic alopecia in women. J. Am. Acad. Dermatol.18, 1073–1077 (1988).
   PubMed Web of Science ®Google Scholar
• Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br. J. Dermatol.127, 239–246 (1992).
   PubMed Web of Science ®Google Scholar
• Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J. Am. Acad. Dermatol.28, 755–763 (1993).
   PubMed Web of Science ®Google Scholar
• Mahé YF, Michelet JF, Billoni N et al. Androgenetic alopecia and microinflammation. Int. J. Dermatol.39, 576–584 (2000).
   PubMed Web of Science ®Google Scholar
• Kossard S. Postmenopausal frontal fibrosing alopecia. Arch. Dermatol.130, 770–774 (1994).
   PubMedGoogle Scholar
• Zinkernagel MS, Trüeb RM. Fibrosing alopecia in a pattern distribution. Patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern? Arch. Dermatol.136, 205–211 (2000).
   PubMedGoogle Scholar
• Philpott MP, Sander DA, Bowen J, Kealey T. Effects of interleukins, colony stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-α in alopecia areata. Br. J. Dermatol.135, 942–948 (1996).
   PubMed Web of Science ®Google Scholar
• Kligman AM. The comparative histopathology of male-pattern baldness and senescent baldness. Clin. Dermatol.6, 108–118 (1988).
   PubMed Web of Science ®Google Scholar
• Paradi M, Shahee O, Shaza D et al. Comparison of senescent and androgenetic alopecia using microarray analysis. Presented at: The 5th Intercontinental Meeting of Hair Research Societies. Vancouver, Canada, 13–16 June 2007 (Abstract O-10–13).
   Google Scholar
• Eichmüller S, van der Veen C, Mill I et al. Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion. J. Histochem. Cytochem.46, 361–370 (1998).
   PubMed Web of Science ®Google Scholar
• Price V, Sawaya M, Headington J, Kibarian M. Histology and hormonal activity in senescent thinning in males. J. Invest. Dermatol.117, 434 (2001) (Abstract 266).
   Web of Science ®Google Scholar
• Courtois M, Loussouarn G, Hourseau C, Grollier JF. Aging and hair cycles. Br. J. Dermatol.132, 86–93 (1995).
   PubMed Web of Science ®Google Scholar
• Mosley JG, Gibbs CC. Premature grey hair and hair loss among smokers: a new opportunity for health education? Br. Med. J.313, 1616 (1996).
   PubMed Web of Science ®Google Scholar
• Trüeb RM. Association between smoking and hair loss: another opportunity for health education against smoking? Dermatology206, 189–191 (2003).
   PubMed Web of Science ®Google Scholar
• Trüeb RM. Is androgenetic alopecia a photoaggravated dermatosis? Dermatology207, 343–348 (2003).
   PubMed Web of Science ®Google Scholar
• Camacho F, Moreno JC, Garcia-Hernández MJ. Telogen alopecia from UV rays. Arch. Dermatol.132, 1398–1399 (1996).
   PubMedGoogle Scholar
• Johnsson A, Kjeldstad B, Melo TB. Fluorescence from pilosebaceous follicles. Arch. Dermatol. Res.279, 190–193 (1987).
   PubMed Web of Science ®Google Scholar
• Piérard-Franchimont C, Uhoda I, Saint-Léger D, Piérard GE. Androgenetic alopecia and stress-induced premature senescence by cumulative ultraviolet light exposure. Exog. Dermatol.1, 203–206 (2002).
   Google Scholar
• Pande CM, Albrecht L, Yang B. Hair photoprotection by dyes. J. Cosmet. Sci.52, 377–389 (2001).
   PubMed Web of Science ®Google Scholar
• Gao T, Bedell A. Ultraviolet damage on natural gray hair and ist photoprotection. J. Cosmet. Sci.52, 103–118 (2001).
   PubMed Web of Science ®Google Scholar
• Wissing SA, Muller RH. Solid lipid nanoparticles (SLN) – a novel carrier for UV blockers. Pharmazie56, 783–786 (2001).
   PubMed Web of Science ®Google Scholar
• Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). Arch. Dermatol. Res.288, 522–526 (1996).
   PubMed Web of Science ®Google Scholar
• Bouillon C. Shampoos. Clin. Dermatol.14, 113–121 (1996).
   PubMed Web of Science ®Google Scholar
• Sieve B. Darkening of gray hair following para-aminobenzoic acid. Science94, 257–258 (1941).
   PubMedGoogle Scholar
• Zarafonetis C. Darkening of gray hair during para-aminobenzoic acid therapy. J. Invest. Dermatol.15, 399–491 (1950).
   PubMed Web of Science ®Google Scholar
• Tosti A, Piraccini BM, van Neste DJ. Telogen effluvium after allergic contact dermatitis of the scalp. Arch. Dermatol.137, 187–190 (2001).
   PubMedGoogle Scholar
• Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br. J. Dermatol.150, 186–194 (2004).
   PubMed Web of Science ®Google Scholar
• Olsen EA, Weiner MS, Delong ER et al. Topical minoxidil in early male pattern baldness. J. Am. Acad. Dermatol.13, 185–192 (1985).
   PubMed Web of Science ®Google Scholar
• Olsen EA, DeLong ER, Weiner MS. Long-term follow-up of men with male pattern baldness treated with topical minoxidil. J. Am. Acad. Dermatol.16, 688–695 (1987).
   PubMed Web of Science ®Google Scholar
• Olsen EA, Weiner MS, Amara IA, DeLong ER. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J. Am. Acad. Dermatol.22, 643–646 (1990).
   PubMed Web of Science ®Google Scholar
• Price VH, Menefee E. Quantitative estimation of hair growth I. Androgenetic alopecia in women: effect of minoxidil. J. Invest. Dermatol.95, 683–687 (1990).
   PubMed Web of Science ®Google Scholar
• De Villez RL, Jacobs JP, Szpunar CA, Warner ML. Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. Arch. Dermatol.3, 303–307 (1994).
   Google Scholar
• Olsen EA, Dunlap FE, Funicella T et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J. Am. Acad. Dermatol.47, 377–385 (2002).
   PubMed Web of Science ®Google Scholar
• Lucky AW, Piacquadio DJ, Ditre CM et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J. Am. Acad. Dermatol.50, 541–553 (2004).
   PubMed Web of Science ®Google Scholar
• Rundegren J. Pattern alopecia: what clinical features determine the response to topical minoxidil treatment? J. Dtsch. Dermatol. Ges.2, 500 (2004) (Abstract B2.4).
   Google Scholar
• Kaufman KD, Olsen EA, Whiting DA, et al. Finasteride in the treatment of androgenetic alopecia. J. Am. Acad. Dermatol.39, 578–589 (1998).
   PubMed Web of Science ®Google Scholar
• Leyden J, Dunlap F, Miller B, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J. Am. Acad. Dermatol.40, 930–937 (1999).
   PubMed Web of Science ®Google Scholar
• The Finasteride Male Pattern Hair Loss Study Group. Long-term (5-year) multination experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur. J. Dermatol.12, 38–49 (2003).
   Web of Science ®Google Scholar
• Brenner S, Matz H. Improvement in androgenetic alopecia in 53–76-year-old men using oral finasteride. Int. J. Dermatol.38, 92–930 (1999).
   Web of Science ®Google Scholar
• Whiting DA, Olsen EA, Savin R et al. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss. Eur. J. Dermatol.13, 150–160 (2003).
   PubMed Web of Science ®Google Scholar
• Whiting DA, Waldstreicher J, Sanchez M, Kaufman KD. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women. J. Invest. Dermatol. Symp. Proc.4, 282–284 (1999).
   PubMedGoogle Scholar
• Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J. Invest. Dermatol.109, 296–300 (1997).
   PubMed Web of Science ®Google Scholar
• Shum KW, Cullen DR, Messenger AG. Hair loss in women with hyperandrogenism: four cases responding to finasteride. J. Am. Acad. Dermatol.47, 733–739 (2002).
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertil. Steril.79, 91–95 (2003).
   PubMed Web of Science ®Google Scholar
• Thai KE, Sinclair RD. Finasteride for female androgenetic alopecia. Br. J. Dermatol.147, 812–813 (2002).
   PubMed Web of Science ®Google Scholar
• Trüeb RM, Swiss Trichology Study Group. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women. Dermatology209, 202–207 (2004).
   PubMed Web of Science ®Google Scholar
• Olsen EA, Hordinsky M, Roberts JL, Whiting DA. Female pattern hair loss. J. Am. Acad. Dermatol.47, 795 (2002).
   PubMed Web of Science ®Google Scholar
• Chein E. Age Reversal, From Hormones to Telomeres. WorldLink Medical Publishing, UT, USA (1998).
   Google Scholar
• Lurie R, Ben-Amitai D, Laron Z. Laron syndrome (primary growth hormone insensitivty): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair. Dermatology208, 314–318 (2004).
   PubMed Web of Science ®Google Scholar
• Stough DB, Potter TS. Philosophy and technique in hair restoration surgery. Curr. Prob. Dermatol.9, 113–136 (1997).
   Google Scholar
• Piérard GE, Piérard-Franchimont C, Nikkels-Tassoudji N et al. Improvement in the inflammatory aspect of androgenetic alopecia. A pilot study with an antimicrobial lotion. J. Dermatol. Treat.7, 153–157 (1996).
   Web of Science ®Google Scholar
• Trüeb RM. Dermocosmetic aspects of hair and scalp. J. Investig. Dermatol. Symp. Proc.10, 289–292 (2005).
   PubMedGoogle Scholar
• Hoffman RM. Topical liposome targeting of dyes, melanins, genes, and proteins electively to hair follicles. J. Dermatol. Treat.5, 67–74 (1998).
   Google Scholar
• Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Christiano AM, Jahoda CAB. Trans-gender induction of hair follicles. Human follicle cells can be induced to grow in an incompatible host of the other sex. Nature402, 33–34 (1999).
   PubMed Web of Science ®Google Scholar
• Stenn KS, Cotsarelis. Bioengineering the hair follicle: fringe benefits of stem cell technology. Curr. Opin. Biotechnol.16, 493–497 (2005).
   PubMed Web of Science ®Google Scholar
• Richardson GF, Arnott EC, Whitehouse CJ et al. Plasticity of rodent and human hair follicle dermal cells: implications for cell therapy and tissue engineering. J. Investig. Dermatol. Symp. Proc.10, 180–183 (2005).
   PubMedGoogle Scholar
• Cotsarelis G. Epithelial stem cells: a folliculocentric view. J. Invest. Dermatol.126, 1459–1468 (2006).
   PubMed Web of Science ®Google Scholar
• Cooley J. Follicular cell implantation: an update on ‘hair follicle cloning.’ Facial Plast. Surg. Clin. North. Am.12, 219–224 (2004).
   PubMedGoogle Scholar